Fondazione Policlinico Gemelli Unità di Fase 1: Unità di Farmacologia Clinica
Fondazione Policlinico Gemelli Unità di Fase 1: Unità di Farmacologia Clinica
Roma, Roma, Italy1 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I Study to Evaluate the Safety and Efficacy of L19IL2 in Combination With Ruxolitinib in Patients With Advanced Solid Tumors | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, pancreatic adenocarcinoma, rectal disorder | Not yet recruiting | Phase 1 | 2026-05-05 | NCT07566897 |